Metraipolis › archive › dc_ab84739571ff

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors — Europe PMC PMID:42100424

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42100424
DOI
10.3389/fonc.2026.1786385
License (as archived)
solo-consultazione
Archived
2026-11-03T07:28:05.512Z
SHA-256 of the archived text
ff85cfe7b64079e8b978b9f7e44580e7c35b62c4abe4bfa6dc7ef6a7a5628921
Stable URL of this page
https://metraipolis.com/documento/dc_ab84739571ff

How to cite

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors — Europe PMC PMID:42100424 — Europe PMC (en), https://europepmc.org/article/MED/42100424 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab84739571ff (Metraipolis archive dc_ab84739571ff, sha256 ff85cfe7b64079e8b978b9f7e44580e7c35b62c4abe4bfa6dc7ef6a7a5628921)
BibTeX
@misc{dcab84739571ff,
  title = {Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors — Europe PMC PMID:42100424},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42100424},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab84739571ff; sha256 ff85cfe7b64079e8b978b9f7e44580e7c35b62c4abe4bfa6dc7ef6a7a5628921},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42100424. Agents can read the archived copy with the MCP tool read_document.